Related Experiment Video
Updated: Mar 9, 2026

Maintenance of a Lateral Fluid Percussion Injury Device
Published on: April 21, 2023
Insights
Most medical devices for children lack Food and Drug Administration (FDA) approval. Off-label use of these devices is often necessary and appropriate for pediatric care, despite regulatory complexities.
Area of Science:
- Pediatric Medical Devices
- Regulatory Science
- Clinical Practice
Background:
- Most medical and surgical devices used in children lack specific Food and Drug Administration (FDA) approval for pediatric use.
- Off-label or physician-directed use of FDA-approved devices is a common and often necessary practice in pediatric medicine and surgery.
Purpose of the Study:
- To describe the appropriateness of off-label device use in children.
- To discuss FDA regulatory pathways for pediatric devices, including the Humanitarian Device Exemption.
- To highlight the need for increased pediatric device labeling.
Main Methods:
- Policy statement analysis.
- Review of FDA regulatory frameworks for medical devices.
- Examination of challenges in pediatric device development.
Main Results:
- Off-label use of medical devices, even high-risk ones, is a necessary component of pediatric care due to unmet needs and development challenges.
- Regulatory pathways like the Humanitarian Device Exemption can cause confusion regarding device experimental status.
- Significant economic and market barriers hinder the development of new pediatric devices.
Conclusions:
- Off-label device use in children is appropriate and essential.
- Enhanced pediatric device labeling is crucial for safe and effective care.
- Addressing regulatory and economic barriers is vital to improve pediatric device availability.
Abstract:
Despite widespread therapeutic needs, the majority of medical and surgical devices used in children do not have approval or clearance from the Food and Drug Administration (FDA) for use in pediatric populations. The clinical need for devices to diagnose and treat diseases or conditions occurring in children has led to the widespread and necessary practice in pediatric medicine and surgery of using approved devices for "off-label" or "physician-directed" applications that are not included in FDA-approved labeling. This practice is common and often appropriate, even with the highest-risk (class III) devices. The legal and regulatory framework used by the FDA for devices is complex, and economic or market barriers to medical and surgical device development for children are significant. Given the need for pediatric medical and surgical devices and the challenges to pediatric device development, off-label use is a necessary and appropriate part of care. In addition, because of the relatively uncommon nature of pediatric conditions, FDA clearance or approval often requires other regulatory pathways (eg, Humanitarian Device Exemption), which can cause confusion among pediatricians and payers about whether a specific use, even of an approved device, is considered experimental. This policy statement describes the appropriateness of off-label use of devices in children; the use of devices approved or cleared through the FDA regulatory processes, including through the Humanitarian Device Exemption; and the important need to increase pediatric device labeling information for all devices and especially those that pose the highest risk to children.
Related Concept Videos
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

